PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Apr-2021 Frequency Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference Businesswire
09-Apr-2021 Global Language Services Market (2021 to 2026) - Growth, Trends, COVID-19 Impact, and Forecasts - ResearchAndMarkets.com Businesswire
09-Apr-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Apr-2021 Global Reefer Container Market Analysis Report 2020-2030: Size (20 Feet, 40 Feet, More than 40 Feet), Transportation Mode (Seaways, Roadways, Railways) - ResearchAndMarkets.com Businesswire
09-Apr-2021 Worldwide Pharmacovigilance and Drug Safety Software Industry to 2025 - Key Drivers, Challenges and Trends - ResearchAndMarkets.com Businesswire
09-Apr-2021 MiNA Therapeutics Presents Translational Data at AACR Supporting MTL-CEBPA as Immunological Cancer Combination Treatment Businesswire
09-Apr-2021 Global NASH Markets, 2016-2020 & 2021-2026: Analysis by Drug Type, Sales Channel, Region, Country - Market Insights, Covid-19 Impact, Competition and Forecast - ResearchAndMarkets.com Businesswire
09-Apr-2021 Sensorion Announces That a General Meeting of Shareholders Will Be Held Behind Closed Doors on May 18, 2021 Alongside the Publication of Its 2020 Annual Financial Report Businesswire
09-Apr-2021 Transgene Presents Initial Phase I Data of TG6002, Highlighting the Potential of the Intravenous Administration of Its Oncolytic Viruses Businesswire
09-Apr-2021 Nimbus Therapeutics Presents In Vivo Data Showing Single-Agent and Combination Activity of HPK1 Inhibitor Businesswire
09-Apr-2021 Palleon Pharmaceuticals Presents Data Suggesting Role of Hypersialylation in Metastatic Melanoma Patients’ Resistance to PD1 Inhibitors Businesswire
09-Apr-2021 Organon Announces Pricing of Senior Notes Offering Businesswire
08-Apr-2021  CORRECTING and REPLACING Bristol Myers Squibb Announces Opdivo (nivolumab) plus Chemotherapy and Opdivo plus Yervoy (ipilimumab) Demonstrate Superior Survival Benefit Compared to Chemotherapy in Unresectable Advanced or Metastatic Esophageal... Businesswire
08-Apr-2021 Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Atos SE (AEXAY) on Behalf of Investors Businesswire
08-Apr-2021 TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium Businesswire
08-Apr-2021 Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update Businesswire
08-Apr-2021 Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer Businesswire
08-Apr-2021 Exclusive Speaker Interview with Achim Kless, Pain Genetics Lead from Eli Lilly & Company ahead of Pain Therapeutics  SMi Group
08-Apr-2021 Elite ServiceNow Partner Edgile Releases ArC Q1 Update Businesswire
08-Apr-2021 A Preclinical Trial Demonstrates the Benefits of Inhaled Pherecydes Pharma Phages in Treating Ventilation-Associated Pneumonia Businesswire